| abstract |
RG-Cysteic Acid (i.e., RG-NH-CH (CH 2 -SO 3 H) COOH or Arg-Gly-NH-CH (CH 2 -SO 3 H) COOH] Such as, for example, pharmaceutically acceptable salts, hydrates, stereoisomers, multimers, cyclic forms, linear forms, drug-conjugates, ≪ / RTI > pro-drugs and derivatives thereof. Inhibition of cellular adhesion to RGD binding sites in human or animal subjects, production of such compounds including methods of delivering other diagnostic or therapeutic agents to RGD binding sites, and Methods for use are also shown. |